Search alternatives:
significant substantial » significant potential (Expand Search), significant spatial (Expand Search)
substantial decrease » substantial increase (Expand Search), substantially increased (Expand Search)
significant trend » significant threat (Expand Search), significant threats (Expand Search), significant burden (Expand Search)
trend decrease » teer decrease (Expand Search)
Showing 1 - 20 results of 10,245 for search '(( significant substantial decrease ) OR ( significant trend decrease ))', query time: 1.48s Refine Results
  1. 1
    Cohesion characteristics and statistical significance analysis of different ingredients across IDDSI levels<sup>b'*'</sup>.

    Cohesion characteristics and statistical significance analysis of different ingredients across IDDSI levels<sup>b'*'</sup>. by Muxi Chen (9294270)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2
    Adhesion characteristics and statistical significance analysis of different ingredients across IDDSI levels<sup>b'*'</sup>.

    Adhesion characteristics and statistical significance analysis of different ingredients across IDDSI levels<sup>b'*'</sup>. by Muxi Chen (9294270)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 3
    Hardness characteristics and statistical significance analysis of different ingredients across IDDSI levels<sup>b'*'</sup>.

    Hardness characteristics and statistical significance analysis of different ingredients across IDDSI levels<sup>b'*'</sup>. by Muxi Chen (9294270)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 4
    Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  5. 5
    Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  6. 6
    Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  7. 7
    Trends in the days of sulfamethoxazole-trimethoprim therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of sulfamethoxazole-trimethoprim therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  8. 8
    Trends in the days of third-generation cephalosporin therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of third-generation cephalosporin therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  9. 9
    Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  10. 10
    Trends in in-hospital mortality by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in in-hospital mortality by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  11. 11
    Distribution of the same ingredient across different IDDSI levels (Percentages and frequencies) and statistical significance analysis (Chi-square analysis).

    Distribution of the same ingredient across different IDDSI levels (Percentages and frequencies) and statistical significance analysis (Chi-square analysis). by Muxi Chen (9294270)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 12
    Trends in the length of hospital stay by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the length of hospital stay by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  13. 13
    Distribution of different ingredients at the same IDDSI level (Percentage and frequency) and statistical significance analysis (Chi-square test)<sup>b'*'</sup>.

    Distribution of different ingredients at the same IDDSI level (Percentage and frequency) and statistical significance analysis (Chi-square test)<sup>b'*'</sup>. by Muxi Chen (9294270)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 14
    Trends in the incidence of resistant <i>Haemophilus influenzae</i> per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of resistant <i>Haemophilus influenzae</i> per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).... by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  15. 15
    Trends in the incidence of <i>Clostridioides difficile</i> infection (CDI) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of <i>Clostridioides difficile</i> infection (CDI) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phas... by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  16. 16
    Trends in the incidence of extended-spectrum β-lactamase (ESBL)- producing Enterobacteriaceae per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of extended-spectrum β-lactamase (ESBL)- producing Enterobacteriaceae per 1000 patients, by month, during the pre-intervention period (Phase 1) and interven... by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  17. 17
    Trends in the incidence of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional pe... by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  18. 18
    Trends in the incidence of penicillin-resistant <i>Streptococcus pneumoniae</i> (PRSP) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of penicillin-resistant <i>Streptococcus pneumoniae</i> (PRSP) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional... by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  19. 19
    Trends analysis in diabetes mellitus diagnosis according to relative handgrip strength.

    Trends analysis in diabetes mellitus diagnosis according to relative handgrip strength. by Yeo Ju Sohn (18536198)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 20
    Dilated Cardiomyopathy-related mortality trends from 1999 to 2023, stratified by Urbanization in the United States.

    Dilated Cardiomyopathy-related mortality trends from 1999 to 2023, stratified by Urbanization in the United States. by Zian Zafar Cheema (22446246)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: